| Literature DB >> 33209376 |
Yong Mao1, Yuting Lan2,3, Fei Cui2, Hongsheng Deng2, Yaoliang Zhang4, Xi Wu4, Wenhua Liang2, Jun Liu2, Hengrui Liang2, Jianxing He2.
Abstract
BACKGROUND: Different video-assisted thoracoscopic surgery (VATS) approaches may related to heterogeneous clinical outcomes in anterior mediastinal tumor surgery. Herein, we assessed the comparison between the subxiphoid and intercostal approach, and also compare the left versus the right incision in the intercostal approach for anterior mediastinal tumor patients.Entities:
Keywords: Mediastinal tumor; intercostal approach; subxiphoid approach
Year: 2020 PMID: 33209376 PMCID: PMC7656433 DOI: 10.21037/jtd-20-266
Source DB: PubMed Journal: J Thorac Dis ISSN: 2072-1439 Impact factor: 2.895
Figure 1Schema of patient grouping and matching.
Demographic characters of patients with subxiphoid approach and intercostal approach before and after 1:1 propensity score matching
| Variables | All patients | Matched patients | |||||
|---|---|---|---|---|---|---|---|
| Subxiphoid approach (n=40) | Intercostal approach (n=198) | SMD | Subxiphoid approach (n=39) | Intercostal approach (n=39) | SMD | ||
| Age (year, | 48.8±14.4 | 47.4±14.5 | <0.001 | 48.3±14.3 | 42.9±16.7 | <0.001 | |
| Gender (male/female) | 21/19 | 99/99 | <0.001 | 21/18 | 20/19 | <0.001 | |
| BMI (kg/m2, | 23.24±3.13 | 23.10±3.26 | <0.001 | 23.23±3.17 | 23.35±3.37 | <0.001 | |
| Pulmonary function test | <0.001 | <0.001 | |||||
| FVC (L) | 3.36±0.88 | 3.31±0.85 | <0.001 | 3.36±0.88 | 3.07±0.94 | <0.001 | |
| FEV1 (L) | 2.66±0.80 | 2.63±0.77 | <0.001 | 2.66±0.80 | 2.51±0.82 | <0.001 | |
| Tumor position (%) | 0.576 | <0.001 | |||||
| Upper mediastinum | 2 (5.0) | 19 (9.6) | 2 (5.1) | 2 (5.1) | |||
| Anterior mediastinum | 38 (95.0) | 126 (63.6) | 37 (94.9) | 37 (94.9) | |||
| Middle mediastinum | 0 | 51 (25.8) | 0 | 0 | |||
| Posterior mediastinum | 0 | 2 (1.0) | 0 | 0 | |||
| Lesion diameter (cm) | 7.1±3.0 | 6.0±3.2 | 0.016 | 7.1±3.0 | 5.9±2.4 | 0.027 | |
| ASA status class (%) | 0.023 | <0.001 | |||||
| I | 0 | 15 (7.6) | 0 | 0 | |||
| II | 40 (100.0) | 178 (89.9) | 39 (100.0) | 38 (97.4) | |||
| III | 0 | 5 (2.5) | 0 | 1 (2.6) | |||
| Comorbidity (%) | 0.057 | <0.001 | |||||
| Hypertension | 2 (5.0) | 15 (7.6) | 2(5.1) | 6 (15.4) | |||
| Coronary heart disease | 0 | 1 (0.5) | 0 | 1 (2.6) | |||
| Diabetes | 1 (2.5) | 2 (1.0) | 1 (2.6) | 0 | |||
| Other | 7 (17.5) | 20 (10.1) | 6 (15.4) | 4 (10.3) | |||
BMI, body mass index; FVC, forced vital capacity; FEV1, forced expiratory volume in 1 second; ASA, American Society of Anesthesiologists; SD, standard deviation.
Demographic characters of patients with left thoracic approach and right thoracic approach after 1:1 propensity score matching
| Variables | All patients | Matched patients | |||||
|---|---|---|---|---|---|---|---|
| Left-side group (n=87) | Right-side group (n=111) | SMD | Left-side group (n=81) | Right-side group (n=81) | SMD | ||
| Age (year, | 47.2±14.6 | 47.5±17.4 | <0.001 | 47.0±14.7 | 45.8±14.6 | <0.001 | |
| Gender (male/female) | 44/43 | 55/56 | <0.001 | 41/40 | 35/46 | <0.001 | |
| BMI (kg/m2, | 23.28 | 22.73 | <0.001 | 23.3±3.3 | 22.7±3.4 | <0.001 | |
| Pulmonary function test | |||||||
| FVC (L) | 3.24±0.85 | 3.37±0.85 | <0.001 | 3.24±0.85 | 3.35±0.92 | <0.001 | |
| FEV1 (L) | 2.57±0.77 | 2.68±0.77 | <0.001 | 2.57±0.75 | 2.69±0.82 | <0.001 | |
| Tumor position (%) | 0.113 | <0.001 | |||||
| Upper mediastinum | 7 (8.0) | 12 (10.8) | 6 (7.4) | 10 (12.3) | |||
| Anterior mediastinum | 57 (65.5) | 69 (62.2) | 53 (65.4) | 45 (55.6) | |||
| Middle mediastinum | 22 (25.3) | 29 (26.1) | 22 (27.2) | 25 (30.9) | |||
| Posterior mediastinum | 1 (1.1) | 1 (0.9) | 0 | 1 (1.2) | |||
| Lesion diameter (cm) | 6.2±2.9 | 5.9±3.4 | 0.594 | 6.3±2.9 | 5.8±3.6 | 0.041 | |
| ASA status class (%) | 0.148 | <0.001 | |||||
| I | 6 (6.9) | 9 (8.1) | 6 (7.4) | 8 (9.9) | |||
| II | 78 (89.7) | 100 (90.1) | 73 (90.1) | 71 (87.7) | |||
| III | 3 (3.4) | 2 (1.8) | 2 (2.5) | 2 (2.5) | |||
| Comorbidity (%) | 0.119 | <0.001 | |||||
| Hypertension | 4 (4.6) | 11 (9.9) | 4 (4.9) | 11 (13.6) | |||
| Coronary heart disease | 1 (1.1) | 0 | 0 | 0 | |||
| Diabetes | 1 (1.1) | 1 (0.9) | 0 | 1 (1.2) | |||
| Other | 8 (9.2) | 12 (10.8) | 4 (4.9) | 8 (9.9) | |||
BMI, body mass index; FVC, forced vital capacity; FEV1, forced expiratory volume in 1 second; ASA, American Society of Anesthesiologists; SD, standard deviation.
Postoperative recovery of patients with subxiphoid approach and intercostal approach
| Variables | Subxiphoid approach (n=19) | Intercostal approach (n=19) | P value |
|---|---|---|---|
| Chest tube duration (day) | 1.9±1.4 | 1.7±2.5 | 0.738 |
| Drainage of the total (mL) | 360.3±410.3 | 255.6±295.4 | 0.209 |
| Total length of stay (day) | 3.3±2.6 | 5.4±3.2 | 0.077 |
Postoperative recovery of patients with left thoracic approach and right thoracic approach
| Variables | Left-side group (n=81) | Right-side group (n=81) | P value |
|---|---|---|---|
| Chest tube duration (day) | 1.9±2.3 | 1.2±1.2 | 0.016 |
| Drainage of the total (mL) | 312.1±462.4 | 193.9±231.3 | 0.041 |
| Total length of stay (day) | 5.3±3.4 | 4.1±3.6 | 0.043 |
Post-operative index comparison between subxiphoid approach and intercostal approach
| Variables | Subxiphoid approach (n=19) | Intercostal approach (n=19) | P value |
|---|---|---|---|
| Coagulation function | |||
| PLT (n/L) | 192.6±42.6 | 234.7±69.2 | 0.002 |
| PT (s) | 14.2±0.81 | 13.3±0.76 | 0.000 |
| APTT (s) | 37.2±2.84 | 38.6±3.63 | 0.111 |
| TT (s) | 15.9±1.53 | 16.9±1.17 | 0.004 |
| FIB (g/L) | 2.9±0.80 | 3.7±1.1 | 0.004 |
| D-dimer (μg/L) | 1,383.8 | 480.0 | 0.001 |
| Arterial blood gas | |||
| PH | 7.31 | 7.34 | 0.112 |
| PaCO2 (mmHg) | 50.0±8.7 | 43.7±4.5 | 0.026 |
| PaO2 (mmHg) | 90.7±31.0 | 105.6±37.0 | 0.283 |
| HCO3- (mmol/L) | 24.0±3.1 | 23.0±2.2 | 0.348 |
| Be (mmol/L) | −2.18±2.8 | 1.70±14.8 | 0.381 |
| Lactic acid (mmol/L) | 1.65±0.7 | 1.93±1.4 | 0.387 |
Post-operative index comparison between left thoracic approach and right thoracic approach
| Variables | Left-side group (n=81) | Right-side group (n=81) | P value |
|---|---|---|---|
| Coagulation function | |||
| PLT (n/L) | 245.8±66.4 | 226.2±52.3 | 0.039 |
| PT (s) | 13.3±0.67 | 13.3±0.68 | 0.972 |
| APTT (s) | 38.4±3.5 | 38.2±4.3 | 0.744 |
| TT (s) | 17.0±1.0 | 16.8±1.0 | 0.104 |
| FIB (g/L) | 3.4±1.0 | 3.7±4.1 | 0.469 |
| D-dimer (μg/L) | 391.6 | 344.3 | 0.498 |
| Arterial blood gas | |||
| PH | 7.35 | 7.35 | 0.847 |
| PaCO2 (mmHg) | 42.7±5.5 | 43.3±5.9 | 0.709 |
| PaO2 (mmHg) | 99.8 | 130.7 | 0.001 |
| HCO3− (mmol/L) | 22.9 | 23.0 | 0.804 |
| Be (mmol/L) | −2.2 | 0.15 | 0.283 |
| Lactic acid (mmol/L) | 1.83±1.0 | 1.43±0.72 | 0.160 |
PLT, platelets; PT, prothrombin time; APTT, activated partial thromboplastin time; TT, thrombin time; FIB, fibrinogen.